scholarly journals Neurotrophic effects of Botulinum neurotoxin type A in hippocampal neurons involve activation of Rac1 by the non-catalytic heavy chain (HCC/A)

2021 ◽  
Author(s):  
Luis Solabre Valois ◽  
Vanilla (Hua) Shi ◽  
Paul Bishop ◽  
Bangfu Zhu ◽  
Yasuko Nakamura ◽  
...  
Keyword(s):  
Heavy Chain ◽  
Hippocampal Neurons ◽  
Botulinum Neurotoxin ◽  
Type A ◽  
Botulinum Neurotoxin Type A

scholarly journals Cloning, expression and purification of botulinum neurotoxin type A heavy chain - crystallographic evidence for a putative tetrameric pore

2012 ◽  
Vol 2 (2) ◽  
pp. 135
Author(s):  
Damodharan Lakshminarasimhan ◽  
Desigan Kumaran ◽  
Rakhi Agarwal ◽  
Bal Ram Singh ◽  
Subramanyam Swaminathan
Keyword(s):  
Heavy Chain ◽  
Botulinum Neurotoxin ◽  
Type A ◽  
Expression And Purification ◽  
Botulinum Neurotoxin Type A

Botulinum neurotoxin type A radiolabeled at either the light or the heavy chain

1989 ◽  
Vol 274 (1) ◽  
pp. 235-240 ◽  
Author(s):  
Michael L. Dekleva ◽  
Bibhuti R. DasGupta ◽  
Venugopal Sathyamoorthy
Keyword(s):  
Heavy Chain ◽  
Botulinum Neurotoxin ◽  
Type A ◽  
Botulinum Neurotoxin Type A

Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients

Immunobiology ◽  
2016 ◽  
Vol 221 (4) ◽  
pp. 568-576 ◽  
Author(s):  
Minako Oshima ◽  
Philip Deitiker ◽  
Joseph Jankovic ◽  
K. Roger Aoki ◽  
M. Zouhair Atassi
Keyword(s):  
T Cells ◽  
Heavy Chain ◽  
Cervical Dystonia ◽  
Botulinum Neurotoxin ◽  
Type A ◽  
Botulinum Neurotoxin Type A ◽  
Terminal Domain

Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle

Toxicon ◽  
2005 ◽  
Vol 46 (2) ◽  
pp. 196-203 ◽  
Author(s):  
S.L. Dodd ◽  
Joshua Selsby ◽  
Anthony Payne ◽  
Andrew Judge ◽  
Christopher Dott
Keyword(s):  
Myosin Heavy Chain ◽  
Heavy Chain ◽  
Botulinum Neurotoxin ◽  
Type A ◽  
Botulinum Neurotoxin Type A ◽  
Chain Composition ◽  
Myosin Heavy Chain Composition

OnabotulinumtoxinA exhibits greater efficacy compared to purified botulinum neurotoxin type A (BoNT/A-150 kDa) in peripheral pain models

Toxicon ◽  
2021 ◽  
Vol 190 ◽  
pp. S70
Author(s):  
Sudhakar R. Subramaniam ◽  
Greg Nicholson ◽  
Brian B. Cai ◽  
Amy D. Brideau-Andersen ◽  
Ron S. Broide
Keyword(s):  
Botulinum Neurotoxin ◽  
Type A ◽  
Botulinum Neurotoxin Type A ◽  
Pain Models ◽  
Peripheral Pain
Sign in / Sign up

Export Citation Format

Share Document